<DOC>
	<DOCNO>NCT00646815</DOCNO>
	<brief_summary>The purpose study characterize treatment related change insulin sensitivity , substrate metabolism intrahepatic-intramyocellular lipid patient growth hormone deficiency ( GHD ) .</brief_summary>
	<brief_title>Insulin Sensitivity Substrate Metabolism Before After Treatment Patients With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Written informed consent Must legal age competent Age : &gt; 18 &lt; 60 year old Presently diagnose growth hormone deficiency ; panhypopituitary , patient must sufficiently substitute axisÂ´s , least 3 month inclusion study Alcohol consumption &gt; 21 unit per week Malignant disease Pregnancy Magnetic implant material body Claustrophobia BMI &gt; 30 Heart disease ( NYHA &gt; 2 ) Uncontrolled hypertension Manifest diabetes mellitus Change medication , influence glucose metabolism , 2 month prior end trial . Controls match age , gender BMI Written inform consent Must legal age competent Alcohol consumption &gt; 21 unit per week Malignant disease Pregnancy Magnetic implant material body Claustrophobia Heart disease ( NYHA &gt; 2 ) Uncontrolled hypertension Manifest diabetes mellitus Change medication , influence glucose metabolism , 2 month prior end trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>insulin sensitivity</keyword>
	<keyword>substrate metabolism</keyword>
	<keyword>fatty liver</keyword>
	<keyword>intramyocellular lipid</keyword>
	<keyword>growth hormone deficiency</keyword>
	<keyword>Growth hormone deficiency ( Adult )</keyword>
</DOC>